Is ImmunoGen, Inc. (IMGN) Stock Worth a Buy Friday?

Friday, October 08, 2021 11:44 AM | InvestorsObserver Analysts

Mentioned in this article

Is ImmunoGen, Inc. (IMGN) Stock Worth a Buy Friday?

ImmunoGen, Inc. (IMGN) stock is higher by 41.40% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives IMGN stock a score of 34 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 22. IMGN's rank also includes a long-term technical score of 36. The fundamental score for IMGN is 45. In addition to the average rating from Wall Street analysts, IMGN stock has a mean target price of $8.10. This means analysts expect the stock to gain 33.22% over the next 12 months.

IMGN has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on IMGN!

See Full IMGN Report

What's Happening with IMGN Stock Today

ImmunoGen, Inc. (IMGN) stock has risen 0.66% while the S&P 500 is higher by 0.01% as of 11:43 AM on Friday, Oct 8. IMGN is higher by $0.04 from the previous closing price of $6.04 on volume of 1,507,535 shares. Over the past year the S&P 500 has gained 27.66% while IMGN is higher by 41.40%. IMGN lost -$0.29 per share in the over the last 12 months. Click Here to get the full Stock Report for ImmunoGen, Inc. stock.